Cargando…
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation
Autores principales: | Sugimori, C, Padron, E, Caceres, G, Shain, K, Sokol, L, Zhang, L, Tiu, R, O'Keefe, C L, Afable, M, Clemente, M, Lee, J M, Maciejewski, J P, List, A F, Epling-Burnette, P K, Araten, D J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317526/ https://www.ncbi.nlm.nih.gov/pubmed/22829258 http://dx.doi.org/10.1038/bcj.2012.7 |
Ejemplares similares
-
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)
por: Lobry, Camille, et al.
Publicado: (2019) -
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria
por: Kulasekararaj, Austin, et al.
Publicado: (2022) -
Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria
por: Mon Père, Nathaniel, et al.
Publicado: (2018) -
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry
por: Schrezenmeier, Hubert, et al.
Publicado: (2020) -
Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
por: Patir, Pusem, et al.
Publicado: (2015)